Study on Azithromycin for Treating Hospitalized Children Aged 1-5 with Asthma Symptoms
- Participants:Children
Rare diseases
Investigational molecules
Locations
Banana flavour is a flavouring agent used in medicines to improve their taste. In the clinical trial record, it appears as an inactive ingredient in an oral preparation. It is not the active substance being tested; the active medicine in this trial is azithromycin, an antibiotic.[1]
Banana flavour does not have a medical effect. It is added to medicines to make them more acceptable to children by masking unpleasant tastes. The trial record does not describe any mechanism of action for banana flavour, because it is not a medicine.[1]
Banana flavour is given orally as part of a liquid or solid oral preparation. In the trial, it is listed as an oral ingredient alongside other inactive substances such as sodium phosphate dodecahydrate, xanthum gum, hydroxypropyl cellulose LF and sucrose.[1] The azithromycin dose in the trial is 500 mg, and the banana flavour amount is listed as 0 mg, meaning the exact quantity was not reported in the register.[1]
One clinical trial involving banana flavour is registered. It is a Phase 2 interventional study with 320 participants, all children aged 1–5 years hospitalised with asthma-like symptoms.[1] The trial compares a three-day course of azithromycin against placebo. The main outcome measured is the duration of the asthma-like episode in days from the start of randomisation.[1] The study is currently authorised, meaning it has received approval to begin.[1] The trial record does not report results yet, so no findings are available at this stage.
No side effects of banana flavour are reported in the provided sources. The trial record does not list adverse events for banana flavour, as it is an inactive ingredient.[1]
Each condition opens its own overview and trial list
Recruiting trials first
Tell us about your condition – we search every trial in Europe and connect you with the right site.